Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Surface Protein gp120 - Drugs in Development, 2021
US$ 3,000.00
Surface Protein gp120 - Drugs in Development, 2021 SUMMARY Surface Protein gp120 - Drugs in Development, 2021 provides in depth analysis on Surface Protein gp120 targeted pipeline therapeutics. The re...
April 2021
70 pages
T-Cell Leukemia (Oncology) - Drugs in Development, 2021
US$ 2,000.00
T-Cell Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY T-Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the T-Cell Leukemia pipeline landscape. The report provi...
April 2021
80 pages
T-Cell Lymphomas (Oncology) - Drugs in Development, 2021
US$ 2,000.00
T-Cell Lymphomas (Oncology) - Drugs in Development, 2021 SUMMARY T-Cell Lymphomas (Oncology) - Drugs in Development, 2021 provides an overview of the T-Cell Lymphomas pipeline landscape. The report pr...
April 2021
125 pages
Testicular Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Testicular Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Testicular Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Testicular Cancer pipeline landscape. The report...
April 2021
40 pages
Thrombosis (Cardiovascular) - Drugs in Development, 2021
US$ 2,000.00
Thrombosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Thrombosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Thrombosis pipeline landscape. The report provides...
April 2021
105 pages
Thymic Carcinoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Thymic Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Thymic Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Thymic Carcinoma pipeline landscape. The report pr...
April 2021
75 pages
Transferrin Receptor (TFR) - Drugs in Development, 2021
US$ 3,000.00
Transferrin Receptor (TFR) - Drugs in Development, 2021 SUMMARY Transferrin Receptor (TFR) - Drugs in Development, 2021 provides in depth analysis on Transferrin Receptor (TFR) targeted pipeline thera...
April 2021
35 pages
